Life Sciences IPOs Take a Breather December 02, 2013 | Press Release
Booming IPO Market Improving M&A Terms for Private Biotechs November 01, 2013 | Press Release
ADMA Biologics, Inc. Announces Pricing October 18, 2013 | Press ReleaseSee all News
Before joining Burrill, Garrett was with Genentech’s Market Planning Group where he focused on the commercialization and launch of Lucentis for the treatment of age-related macular degeneration. Garrett previously worked with the Health Care Investment Banking group at Cowen and in Business Development at EntreMed.
Garrett is a co-instructor at UCSF’s Center for BioEntrepreneurship’s “Idea to IPO” course and has advised in the formation of numerous biotech start-ups. Garrett completed his Transitional Residency at the